RAGUSA ROBERT P
SEC CIK 1222644 · EDGAR
BoughtSold
Most active insiders at ALMR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Illumina Innovation Fund II GP, L.L.C. | 10% | $4.00M | — |
| 2 | Naclerio Nicholas | Dir | $4.00M | — |
| 3 | Chen Shiping | COO, Dir | — | — |
| 4 | Luo Yuling | CEO, Dir | — | — |
| 5 | White Timothy Ogden | Pres | — | — |
| 6 | Qiming Corporate GP VI, Ltd. | 10% | — | — |
| 7 | Brottem John L. | GC | — | — |
| 8 | McAnear Justin J. | CFO | — | — |
| 9 | RAGUSA ROBERT P | Dir | — | — |
Transactions 19
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-03 16:27 | 2026-09-01 | ALMR | Alamar Biosciences, Inc. | RAGUSA ROBERT P | Dir | A - Grant | $0.00 | +5,686 | 5,686 | New | $0 |
| 2026-04-09 18:58 | 2026-04-08 | GRAL | GRAIL, Inc. | RAGUSA ROBERT P | CEO, Dir | S - Sale | $49.92 | -123.5K | 518.6K | -19% | -$6.16M | |
| M | 2026-03-09 | 2026-03-05+ | GRAL | GRAIL, Inc. | RAGUSA ROBERT P | CEO, Dir | S - Sale | $48.48 | -8,441 | 649.5K | -1% | -$409.2K |
| M | 2026-03-03 | 2026-03-02 | GRAL | GRAIL, Inc. | RAGUSA ROBERT P | CEO, Dir | S - Sale | $50.17 | -37.5K | 652.2K | -5% | -$1.88M |
| 2026-02-09 | 2026-02-05 | TWST | Twist Bioscience Corp | RAGUSA ROBERT P | Dir | A - Grant | $0.00 | +5,095 | 29.0K | +21% | $0 | |
| M | 2025-12-05 | 2025-12-03 | GRAL | GRAIL, Inc. | RAGUSA ROBERT P | CEO, Dir | S - Sale | $95.24 | -40.0K | 713.2K | -5% | -$3.81M |
| 2025-10-16 | 2025-10-15 | GRAL | GRAIL, Inc. | RAGUSA ROBERT P | CEO, Dir | S - Sale | $68.88 | -7,239 | 727.4K | -1.0% | -$498.6K | |
| 2025-05-05 | 2025-05-02 | GRAL | GRAIL, Inc. | RAGUSA ROBERT P | CEO, Dir | S - Sale | $33.93 | -94.0K | 734.6K | -11% | -$3.19M | |
| A | 2025-04-03 | 2025-03-11 | GRAL | GRAIL, Inc. | RAGUSA ROBERT P | CEO, Dir | S - Sale | $31.21 | -7,625 | 828.7K | -0.9% | -$238.0K |
| 2025-03-12 | 2025-03-07 | GRAL | GRAIL, Inc. | RAGUSA ROBERT P | CEO, Dir | S - Sale | $31.21 | -7,625 | 828.7K | -0.9% | -$238.0K | |
| 2025-03-06 | 2025-03-05 | GRAL | GRAIL, Inc. | RAGUSA ROBERT P | CEO, Dir | S - Sale | $41.51 | -994 | 836.3K | -0.1% | -$41.3K | |
| 2025-02-07 | 2025-02-05 | TWST | Twist Bioscience Corp | RAGUSA ROBERT P | Dir | A - Grant | $0.00 | +4,472 | 23.9K | +23% | $0 | |
| 2025-02-04 | 2025-02-03 | GRAL | GRAIL, Inc. | RAGUSA ROBERT P | CEO | A - Grant | $28.84 | +224.6K | 837.3K | +37% | +$6.48M | |
| 2024-10-17 | 2024-10-15 | GRAL | GRAIL, Inc. | RAGUSA ROBERT P | CEO | S - Sale | $14.02 | -123.5K | 612.7K | -17% | -$1.73M | |
| M | 2024-10-07 | 2024-10-03 | GRAL | GRAIL, Inc. | RAGUSA ROBERT P | CEO | A - Grant | $12.57 | +260.1K | 690.3K | +60% | +$3.27M |
| 2024-07-02 | 2024-06-28 | GRAL | GRAIL, Inc. | RAGUSA ROBERT P | CEO | A - Grant | $0.00 | +475.2K | 476.0K | +55,447% | $0 | |
| 2024-02-09 | 2024-02-06 | TWST | Twist Bioscience Corp | RAGUSA ROBERT P | Dir | A - Grant | $0.00 | +5,815 | 19.4K | +43% | $0 | |
| 2023-02-09 | 2023-02-07 | TWST | Twist Bioscience Corp | RAGUSA ROBERT P | Dir | A - Grant | $0.00 | +8,212 | 13.6K | +152% | $0 | |
| 2022-02-10 | 2022-02-08 | TWST | Twist Bioscience Corp | RAGUSA ROBERT P | Dir | A - Grant | $0.00 | +3,491 | 5,389 | +184% | $0 |
Purchase Sale Sale after option exercise All abbreviations